ライフサイエンスコーパス: serum albumin

1 hibition with a CCD inhibitor (MUXF(3)-human serum albumin).

2 to lysines 195 and 475 of CLV-treated human serum albumin.

3 ermined that ATRAM binds reversibly to human serum albumin.

4 arance half-life through enhanced binding to serum albumin.

5 ion of a pendant maleimide ligand with human serum albumin.

6 n levels as well as significant reduction of serum albumin.

7 h forms a high molecular weight complex with serum albumin.

8 Disease, Hispanic race, older age and a low serum albumin.

9 ic binding of bovine serum albumin and human serum albumin.

10 e chromatography based purification of human serum albumin.

11 sis of peptides from trypsin digested bovine serum albumin.

12 coli cells and does not interact with bovine serum albumin.

13 ne-derivatized fluorophore-conjugated bovine serum albumin.

14 tibody fragment specific for mouse and human serum albumin.

15 glycine, and beta-mercaptoethanol) and human serum albumin.

16 n, beta-lactoglobulin, soy protein and human serum albumin.

17 inding capacity, transferrin saturation, and serum albumin.

18 m was measured at baseline and corrected for serum albumin.

19 f binding between the lipidated peptides and serum albumin.

20 n combination of calcium alginate and bovine serum albumin.

21 r secretion without the presence of serum or serum albumin.

22 blood was removed and replaced with 5% human serum albumin.

23 y defined albumin supplements such as bovine serum albumin.

24 spiked in a protein digest mixture of bovine serum albumin.

25 oparticles in ethanolic solutions and bovine serum albumin.

26 olled hydrolysis and precipitation of bovine serum albumin.

27 tion calorimetry that JMS-053 binds to human serum albumin.

28 known to exhibit high binding affinities to serum albumin.

29 nt in fetal bovine serum (FBS) identified as serum albumin.

30 unfolding pathway for a group of homologous serum albumins.

31 Serum albumin, 25(OH)D, and intact parathyroid hormone w

32 treatment, were neutropenia (48 [15%]), low serum albumin (33 [10%]), weight loss (29 [9%]), and ana

33 measured charge-state distribution of bovine serum albumin (66.5 kDa), indicating that ion-ion intera

34 near-infrared fluorescent dye-labeled bovine serum albumin (800CW-BSA, used as a model agent).

35 mpletely removes p-cresyl sulfate from human serum albumin, a protein that these uremic toxins bind t

36 th was evaluated, and FITC conjugated bovine serum albumin across monolayer hRECs served as an index

37 cation using electrospun amyloid like-bovine serum albumin (AL-BSA) nanofibers on QCM surfaces.

38 dy mass index, haemoglobin, serum uric acid, serum albumin, albuminuria, and C reactive protein as no

39 49 T, 37 degrees C) in the presence of human serum albumin, allowing a significant MRI signal intensi

40 The contents of two amide-AGEs in human serum albumin and apolipoprotein A-II were significantly

41 The ability to detect miRNA-21 in human serum albumin and bovine serum albumin was almost identi

42 he screening tools, length of hospital stay, serum albumin and cholesterol concentrations, lymphocyte

43 clusters (AuQC@BSA) synthesized using bovine serum albumin and conjugated with acetylcholinesterase (

44 demonstrate protein binding by using bovine serum albumin and detection of antibody-antigen immune r

45 e the morphology of hydrogels made of bovine serum albumin and gelatin following high pressure proces

46 Similarly, among men, lower serum albumin and higher ICS were linked with higher bas

47 to differentially charged epitopes on mouse serum albumin and human epidermal growth factor receptor

48 ant levels of non-specific binding of bovine serum albumin and human serum albumin.

49 S, combining elevated hsCRP and ESR with low serum albumin and iron], and serum interleukin (IL) 1bet

50 With serum albumin and lysozyme adsorption <0.2 ng cm(-2) , t

51 LMG-bovine serum albumin and rabbit anti-sheep IgG were immobilized

52 the pressure effect was performed for bovine serum albumin and thyroglobulin that required gradient s

53 ison of lipid binding to the soluble protein serum albumin and to the integral membrane protein NapA

54 minor (lactoferrin, lactoperoxidase, bovine serum albumin) and major (alpha-lactalbumin, beta-lactog

55 nd effects on inflammation, iron metabolism, serum albumin, and anti-drug antibodies.

56 , cytochrome c, myoglobin, ovalbumin, bovine serum albumin, and etanercept were investigated.

57 cluding elongation factor 1-alpha1 and mouse serum albumin, and found that iTORC reliably detected th

58 of congestive heart failure, and hemoglobin, serum albumin, and serum phosphorus levels.

59 opylene glycol (PPG), angiotensin II, bovine serum albumin, and the "thermometer" compound p-methoxyb

60 ed via the covalent immobilization of bovine serum albumin antibody (anti-BSA) and fibrinogen antibod

61 When measuring a bovine serum albumin aqueous solution, the limit of detection (

62 Chitosan capped gold nanoparticles on bovine serum albumin are proposed as an ultrasensitive plasmoni

63 Using human serum albumin as a model, its sequence was exploited to

64 ing sulforhodamine b, zidovudine, and bovine serum albumin as model hydrophilic drugs, we found tappe

65 elated characteristics (high MELD score, low serum albumin, ascites, encephalopathy), surgery-related

66 identified by X-ray crystallography in human serum albumin at drug site 3, which is also known as sub

67 This work examines the use of serum-albumin-based freestanding mats as macroscopic ele

68 ent of supercharging was probed using bovine serum albumin, beta-lactoglobulin, and lysozyme, each of

69 Human serum albumin binding was measured by affinity high-perf

70 medium-to-low lipophilicity, and high human serum albumin binding.

71 ptide, which lies in Subdomain IIIA of human serum albumin, blocks binding of all three antibodies to

72 deficiency virus status with CD4 count, age, serum albumin, body mass index, and pre-existing hearing

73 Bovine serum albumin (BSA) adsorption was studied at different

74 Meanwhile, the introduction of bovine serum albumin (BSA) and antibody (Ab) enhanced the dispe

75 ns including cardiac myoglobin (MYG), bovine serum albumin (BSA) and cardiac troponin T (cTnT), respe

76 Bovine serum albumin (BSA) and dextran varying in molecular wei

77 ace properties with various proteins (bovine serum albumin (BSA) and different forms of hemoglobin).

78 y (PPC) using two different proteins [bovine serum albumin (BSA) and gelatin], molecular weights, tot

79 nd biodegradability, albumins such as bovine serum albumin (BSA) and human serum albumin (HSA) have f

80 on behavior of two model proteins- i) bovine serum albumin (BSA) and ii) beta-galactosidase (beta-gal

81 siologically relevant components like bovine serum albumin (BSA) and lipopolysaccharide.

82 shells comprising alternate layers of bovine serum albumin (BSA) and tannic acid (TA) were tested as

83 sp.) hydrolyzed iron oxide-associated bovine serum albumin (BSA) and the factors that affected the pr

84 roach with a 4-plex labeled sample of bovine serum albumin (BSA) and yeast lysates mixed at different

85 mug/mL) after passive adsorption and bovine serum albumin (BSA) as a blocking agent generated a mode

86 tting gold nanoclusters (AuNCs) using bovine serum albumin (BSA) as a protecting agent.

87 ly by a bichinchonic acid assay using bovine-serum albumin (BSA) as a protein model on the l-cysteine

88 GSTP), human serum albumin (HSA), and bovine serum albumin (BSA) as model target proteins.

89 es of insulin, alpha-lactalbumin, and bovine serum albumin (BSA) as well as the free C34-BSA were dem

90 ted the interaction of CA and MC with bovine serum albumin (BSA) at pH 3.5, 5.0, and 7.4 using fluore

91 inazolinone core allowed reduction of bovine serum albumin (BSA) binding (63c, 63d).

92 of protein-based hydrogels made from bovine serum albumin (BSA) by using polyelectrolytes such as po

93 tein Fluorescein isothiocynate (FITC) Bovine Serum Albumin (BSA) conjugate incorporated in the sheath

94 ata were collected from a solution of bovine serum albumin (BSA) digested by trypsin as an enzymatic

95 reated with palmitate (50 mumol/L) or bovine serum albumin (BSA) for 24 hr.

96 ) and dodecyl maltoside (DDM) protect bovine serum albumin (BSA) from unfolding in SDS.

97 results of HS-SPME/GC indicated that bovine serum albumin (BSA) had the highest affinity toward safr

98 the mechanism of SA interaction with bovine serum albumin (BSA) has been investigated by multi-spect

99 ent and in vitro release behaviour of bovine serum albumin (BSA) in chitosan-tripolyphosphate (TPP) h

100 t's Reagent (TR) was used to thiolate Bovine serum albumin (BSA) in solution followed by chemical cro

101 he migration of fluorescently labeled bovine serum albumin (BSA) into the nanoslits; and fluorescence

102 eling of a yeast proteome spiked with bovine serum albumin (BSA) over a 10-fold dynamic range.

103 endent adsorption and denaturation of bovine serum albumin (BSA) protein onto a silica-coated array o

104 ient way; LC-MS of a trypsin-digested bovine serum albumin (BSA) sample provided narrow peaks, short

105 biocompatible nanocomposite including bovine serum albumin (BSA) template Cu nanoclusters (CuNCs@BSA)

106 s demonstrated that the adsorption of bovine serum albumin (BSA) to aqueous gold colloids can be quan

107 We illustrate a method that uses bovine serum albumin (BSA) to control the receptor-accessible p

108 lay important roles in the ability of bovine serum albumin (BSA) to form stable nanostructures with b

109 even when the molar ratio of IgG and bovine serum albumin (BSA) tryptic digest mixtures reached to 1

110 As a case study, we choose to monitor bovine serum albumin (BSA) unspecific adsorption, which has bee

111 ining the heat denaturation degree of bovine serum albumin (BSA) was assessed.

112 By culture media modifications, bovine serum albumin (BSA) was identified as blocking initial c

113 In this system, bovine serum albumin (BSA) was immobilized on gold grids as the

114 -3-glucoside (CYG) through binding to bovine serum albumin (BSA) was investigated at pH 3.0 using ato

115 Moreover, the adsorption of bovine serum albumin (BSA) was significantly reduced at the SR

116 he interaction between Allura Red and bovine serum albumin (BSA) was studied in vitro at pH 7.4.

117 immobilized via EDC-NHS chemistry and Bovine serum albumin (BSA) was used for blocking of the non-spe

118 ), alpha-lactalbumin (alpha-Lac), and bovine serum albumin (BSA) were bound to beta-C with overall bi

119 f patients, antibodies against native bovine serum albumin (BSA) were detected.

120 ion followed by a post-treatment with bovine serum albumin (BSA) which served as the blocking agent t

121 tudy, we evaluated the interaction of bovine serum albumin (BSA) with AP and AS using surface plasmon

122 this report, a stepwise unfolding of bovine serum albumin (BSA) with guanidine hydrochloride (GuHCl)

123 psin Inhibitor (TI); Ovalbumin (OVA); Bovine Serum Albumin (BSA)), we observe resolution of the marke

124 -plant leaves at different rates with bovine serum albumin (BSA), a molecular substitute for detritus

125 Compared to Y-tube compartments with bovine serum albumin (BSA), GDNF and NGF increased the motor an

126 mplex with a model transport protein, bovine serum albumin (BSA), have been explored by means of diff

127 h on albumin hydrogels has focused on bovine serum albumin (BSA), leaving human serum albumin (HSA) c

128 roteins including chymotrypsin (chy), bovine serum albumin (BSA), lysozyme (lyz) and cytochrome c (cy

129 deposited gold film and adsorption of bovine serum albumin (BSA), respectively, on poly(methyl methac

130 Bovine serum albumin (BSA), whey protein isolate (WPI), insulin

131 polymerization from the model protein bovine serum albumin (BSA).

132 a simulated biothreat scenario using bovine serum albumin (BSA).

133 prepared from inherent biocompatible bovine serum albumin (BSA).

134 ature (T(d)) and heat-set gelation of bovine serum albumin (BSA).

135 s in the bilayer were backfilled with bovine serum albumin (BSA).

136 Bovine serum albumin (BSA)/curcumin binding and dye photodegrad

137 vity of extracts was evaluated in the bovine serum albumin (BSA)/glucose system.

138 ontaining small (glycerol) and large (bovine serum albumin; BSA) analyte molecules, indicating that t

139 e, sex, time from diagnosis, proteinuria, or serum albumin, but epitope spreading strongly correlated

140 ng affinity between drug molecules and human serum albumin by combining nanoporous anodic alumina rug

141 Further studies are required to confirm that serum albumin can be used as a biomarker to monitor dise

142 he biomimetic nanoparticles (cationic bovine serum albumin (CBSA) conjugated siS100A4 and exosome mem

143 ion strategy based on carbon nanotube-bovine serum albumin (CNT-BSA) hybrid system, by which sensitiv

144 We report the crystal structures of equine serum albumin complexed with four NSAIDs (ibuprofen, ket

145 Serum albumin concentration (p=0.43), thromboprophylaxis

146 Serum albumin concentration was determined before and af

147 sclerosis on initial biopsy as well as age, serum albumin concentration, and CKD stage at onset affe

148 veloped age-dependent PH associated with low serum-albumin concentration.

149 d on the quantitation of extravasated bovine serum albumin conjugated to Evans Blue, as an indicator

150 yptic digests of three model proteins (Human Serum Albumin, creatine kinase, and myoglobin).

151 protein (PGRP) were not detected while camel serum albumin (CSA) was significantly diminished.

152 In diabetes, hepatic production of serum albumin decreases, and it has been long establishe

153 es of the enrichment step from spiked bovine serum albumin digests were >80% for the commercial Fe-IM

154 as densely immobilized conjugates of bovine serum albumin (DNP-BSA) or mobile in a supported lipid b

155 Low serum albumin, elevated lactate dehydrogenase (LDH), hig

156 We encapsulated fluorescent-bovine serum albumin (FITC-BSA) inside the gel.

157 nd fluorescein isothiocyanate-labeled bovine serum albumin (FITC-BSA).

158 Median human serum albumin for OriCols was 14.9 mug/ml, whereas Meroc

159 tochrome c, ubiquitin, myoglobin, and bovine serum albumin formed by electrospray ionization are meas

160 A aptamers specifically bound glycated human serum albumin (GHSA), which is an intermediate marker fo

161 h four reference molecules (dopamine, bovine serum albumin, glucose and elongated peptide) was neglig

162 Centella asiatica phenolics (CAP) on bovine serum albumin glycoxidation in a BSA-glucose model in vi

163 eting highly abundant proteins such as human serum albumin (>10(10) more abundant than cTnI).

164 Serum albumin has long been recognized as a major source

165 related was associated with older age, lower serum albumin, higher blood neutrophil counts, and great

166 The binding of JMS-053 to human serum albumin, however, did not markedly alter the overa

167 rement (LSM) (HR 1.040; 95% CI 1.017-1.064), serum albumin (HR 0.400; 95% CI 0.174-0.923), 1-year Del

168 R = 1.8; 95% CI = 1.2-2.6; P < 0.01) and low serum albumin (HR = 2.1; 95% CI = 1.5-2.9; P < 0.01) wer

169 simple post-adsorption of human serum:bovine serum albumin (HS:BSA) mixtures onto the folic acid modi

170 ith 10% dimethyl sulfoxide (DMSO), 15% human serum albumin (HSA) and 0.1% hyaluronans.

171 as high as 7-fold increase versus the human serum albumin (HSA) and 8-fold increase versus the human

172 pH-dependent conformational changes in human serum albumin (HSA) and cytochrome C by monitoring cross

173 towards the target biomarker proteins (human serum albumin (HSA) and human immunoglobulin G (HIgG)) a

174 rugate filters (NAA-RFs) modified with human serum albumin (HSA) and reflectometric interference spec

175 namics and kinetics of binding between human serum albumin (HSA) and resveratrol (RES) or its analog

176 rchical structure for determination of human serum albumin (HSA) are designed and fabricated.

177 dy was to investigate the potential of human serum albumin (HSA) as a solubilising agent/drug deliver

178 e of a high concentration (500 muM) of human serum albumin (HSA) as an interfering protein in the bac

179 The knowledge on human serum albumin (HSA) binding is of utmost importance as i

180 ghly disulfide-bonded proteins such as human serum albumin (HSA) by online EC reduction of nonreduced

181 These additives interaction with human serum albumin (HSA) can exert considerable effect on the

182 Previously, we showed that human serum albumin (HSA) can increase foreign DNA acquisition

183 on bovine serum albumin (BSA), leaving human serum albumin (HSA) comparatively understudied.

184 noparticle (SPNP) based on polymerized human serum albumin (HSA) equipped with the cell-penetrating p

185 an A2, C1, and C2 domains presented as human serum albumin (HSA) fusion proteins.

186 such as bovine serum albumin (BSA) and human serum albumin (HSA) have found a wide range of biomedica

187 profiled adducts at the Cys34 locus of human serum albumin (HSA) in 29 nonsmoking Xuanwei and Fuyuan

188 The label-free detection of human serum albumin (HSA) in aqueous buffer is demonstrated us

189 hemically induced protein unfolding of human serum albumin (HSA) in great detail.

190 Human serum albumin (HSA) is a natural carrier protein possess

191 uantitative and selective detection of human serum albumin (HSA) is demonstrated with a limit of dete

192 as detected on four lysine residues of human serum albumin (HSA) isolated from tolerant patients.

193 for PSMA and appropriate affinity for human serum albumin (HSA) may demonstrate a higher therapeutic

194 we loaded ATO onto folate (FA)-labeled human serum albumin (HSA) pretreated with glutathione (GSH) ba

195 olution chemistry on the adsorption of human serum albumin (HSA) proteins on graphene oxide (GO) was

196 d (SM) produces a covalent adduct with human serum albumin (HSA) representing an established plasma b

197 Human serum albumin (HSA) serves not only as a physiological o

198 etermined binding affinity of DOX with human serum albumin (HSA) was considered to simplify the mathe

199 e (FITC) after fluorescent labeling of human serum albumin (HSA) with electromembrane extraction (EME

200 ty-lipoprotein (VLDL) yields 1-3%, and human serum albumin (HSA) yields 0-2%.

201 complexes with albumin (in particular, human serum albumin (HSA)) are fundamental for the characteriz

202 glutathione S-transferase pi (hGSTP), human serum albumin (HSA), and bovine serum albumin (BSA) as m

203 ditives, such as Triton X-100 (TX) and human serum albumin (HSA), are not fully understood.

204 antly expressed extracellular protein, human serum albumin (HSA), inhibits alphaS oligomer (alphaS(n)

205 he presence of physiological levels of human serum albumin (HSA), the r(1) relaxivity is amplified fu

206 inhibitor of Abeta self-association is human serum albumin (HSA), which binds approximately 90% of pl

207 s, we rationally developed a drug-free human serum albumin (HSA)-based therapeutic (KH-1) that functi

208 , bovine thyroglobulin (Bos d TG), and human serum albumin (HSA)-conjugated alpha-Gal.

209 adily forms a noncovalent complex with human serum albumin (HSA).

210 proteins to increase their binding to human serum albumin (HSA).

211 ting catechol estrogens (CEs)-adducted human serum albumin (HSA).

212 s of unusually long serum half-life of human serum albumin (HSA).

213 ctures with strong binding affinity to human serum albumin (HSA).

214 cribe the interaction between 2PHE and human serum albumin (HSA).

215 nd l-ascorbic acid were incubated with human serum albumin (HSA).

216 cular details for the interaction with human serum albumin (HSA).

217 ant delivery systems (liposomes and in human serum albumin [HSA]-fusion products) in combination with

218 bining administration of an engineered mouse serum albumin/IL-2 fusion with an Fc fusion to an integr

219 a test line comprised of the protein bovine serum albumin immobilized on nitrocellulose.

220 ious membrane transporters, association with serum albumin in circulatory and extracellular spaces, a

221 K212Hcy) and N-Hcy-Lys525 (K525Hcy) sites in serum albumin in mice.

222 ion, reduced ESA requirements, and increased serum albumin in patients on hemodialysis with inflammat

223 n selective binding to the transport protein serum albumin in PBS buffer at ambient conditions.

224 rtisol solutions in a complex matrix (bovine serum albumin in phosphate buffered saline) is also demo

225 tion limit of ~110 fg/mL biotinylated bovine serum albumin in serum.

226 lysozyme and all 17 disulfide bonds in human serum albumin, including nested disulfide bonds and moti

227 The natural agonist serum albumin induced microneme secretion in a protein k

228 Human serum albumin is an endogenous ligand transport protein

229 m dissociation constant for Zn(2+) and human serum albumin (Kd = (5.62 +/- 0.93) x 10(-7) M) under ph

230 lue resulted in sustained improvement of the serum albumin level and symptoms in 3 patients, temporar

231 lbumin level than men, and stratification by serum albumin level attenuated sex differences in the ag

232 ing treatment with IVIG (2 g/kg), the median serum albumin level decreased to 3.7 g/dL (interquartile

233 el of 82 g/L (reference range, 66-81 g/L), a serum albumin level of 39.3 g/L (reference range, 40.2-4

234 Women had a significantly lower serum albumin level than men, and stratification by seru

235 Before treatment, the median serum albumin level was 4.2 g/dL (interquartile range, 3

236 rum bilirubin, 22.2 mg/dL), hypoalbuminemia (serum albumin level, 2.58 g/dL), coagulopathy (prothromb

237 or differences in health status reflected by serum albumin level.

238 sitive unlike normal Fc interactions and how serum albumin levels are unaffected by DX-2507 binding.

239 Serum albumin levels in the cortex, a measure of BBB bre

240 Serum albumin levels were determined in 174 patients wit

241 sess whether there is an association between serum albumin levels, a widely used and relatively easil

242 months with weight gain and normalization of serum albumin levels.

243 ibrinogen in the presence of high background serum albumin levels.

244 Conjugation of fatty acid, a natural human serum albumin ligand, to a therapeutic protein/peptide w

245 Because the hemin-doped serum albumin mats have both biocompatibility and fabric

246 Free-standing serum-albumin mats can transport protons over millimetre

247 The reversible binding of JMS-053 to serum albumin may serve to increase JMS-053's plasma hal

248 Methylated-bovine serum albumin (mBSA), but not vehicle challenge, in the

249 f non-nephrotic range proteinuria (NNRP) and serum albumin measurements in relation to PLA2R-AB statu

250 ment of the particle supernatant with bovine serum albumin mitigates the negative effects of free or

251 Addition of a human serum albumin molecule prolongs the half-life in a human

252 This carrier consists of mouse serum albumin (MSA) covalently coupled to several PDGFbe

253 however, ion mobility resolution for bovine serum albumin (MW ~ 68 kDa) is less than ~20, which aris

254 than 95% of model biochemical species (human serum albumin, neurotensin, creatinine, glycine, and ala

255 tered when the assay was processed in bovine serum albumin or human serum.

256 8 (MMP-8), minocycline hydrochloride, bovine serum albumin, or an antibacterial peptide (KSL) was inc

257 such as glutathione S-transferase pi (GSTP), serum albumin, or Keap1.

258 Serum albumins, particularly that from bovine origin (BS

259 gh doses (1.5 g/kg every week) of albumin on serum albumin, plasma renin, cardiocirculatory function,

260 suggest that oxo-amino-acids of the protein serum albumin play a major role in the translocation of

261 A bovine serum albumin pretreatment protocol was developed to sta

262 alent binding of biopharmaceuticals to human serum albumin protects against enzymatic degradation and

263 patinib release from a nanoshell-based human serum albumin protein host complex resulted in increased

264 ase, one from creatine kinase, and four from serum albumin protein.

265 evaluating the cerebrospinal fluid (CSF) to serum albumin quotient (QAlb) in patients with primary H

266 oteric compounds, such as hemoglobin, bovine serum albumin, R-phycoerythrin, and histidine, within mi

267 emodin and aloe-emodin derivatives to human serum albumin ranged from -7.30 and -10.62 kcal/mol.

268 protein in CSF, and in BBB permeability (CSF/serum albumin ratio).

269 vels of K212Hcy and K525Hcy modifications in serum albumin relative to their female (n = 19) and male

270 ounds (sucrose, dopamine, starch, and bovine serum albumin), resulting in negligible cross-reactivity

271 and positive co-protein effects with bovine serum albumin, (S-)ovalbumin, egg white, whole egg, defa

272 es and spleen of a systemically administered serum albumin (SA)-IL-4 fusion protein leads to higher e

273 the bloodstream, NSAIDs are mostly bound to serum albumin (SA).

274 The plasmonic construct consists of a bovine serum albumin scaffold with approximately 210 IRDye 800C

275 ctivity 1:400 horse radish peroxidase/bovine serum albumin, sensitivity to 100 attomoles, recovery 89

276 ated using IDA in intact and digested bovine serum albumin solutions using the TCN (98 and 100%, resp

277 tate on structures of native-like cations of serum albumin, streptavidin, avidin, and alcohol dehydro

278 nsional porous matrix of cross-linked bovine serum albumin supported by a network of conductive nanom

279 l as a functionally superior replacement for serum albumin that is compatible with good manufacturing

280 In the presence of serum albumin, the potency of JMS-053 as an in vitro inh

281 blood was removed and replaced with 5% human serum albumin to reduce haemoglobin concentration (n = 8

282 The addition of human serum albumin to the tri-specific inhibitor could allow

283 the intrinsic transport properties of human serum albumin to tune the blood circulatory half-life, h

284 Using the strong affinities of serum albumins towards anions, the increase in cathodic

285 e, we examine the binding of an ABD to human serum albumin using isothermal titration calorimetry and

286 (GSC) and PT uptake of Texas Red-labeled rat serum albumin using two-photon intravital microscopy.

287 t miRNA-21 in human serum albumin and bovine serum albumin was almost identical to that in PBS.

288 Finally, HOCl-modified serum albumin was found to act as a pro-survival molecul

289 Finally, human serum albumin was found to bind NO2-CLA both non-covalen

290 re, the interaction between KP1019 and human serum albumin was investigated by means of X-ray crystal

291 Serum albumin was measured from January 13 to 20, 2011.

292 A mass balance model based on bovine serum albumin-water (D(BSA/w)) and liposome-water distri

293 id-IR spectra of Escherichia coli and bovine serum albumin were recorded.

294 sing is inhibited by physiological levels of serum albumin, which appears to bind and sequester some

295 tase 4A3 binds to at least one site on human serum albumin, which is likely to extend the compound's

296 e focused on modifications to Cys34 in human serum albumin, which is responsible for scavenging small

297 blood proteins, particularly Cys34 of human serum albumin, which is the dominant scavenger of reacti

298 -specific antibody linked in tandem to human serum albumin, which retained FcgammaR-binding activity

299 ibody binding site, HSA Peptide 40, on human serum albumin with nanomolar affinity for all three mono

300 ically adsorbed films of the protein, bovine serum albumin, with different alpha-helix and beta-sheet